ARCHIVE
№1' 2008
CARDIOLOGYInternational Medical Journal, Vol. 14., Iss. 1, 2008, P. 68−70.
THE INFLUENCE OF COMPLEX THERAPY FOR METABOLIC SYNDROME ON CYTOKINE METABOLISM FEATURES
Kharkiv National Medical University, Kharkiv, Ukraine
It is shown that the use of lisinopril and carvedilol in complex treatment of the patients with coronary artery disease and chronic heart failure accompanied by type 2 diabetes mellitus and metabolic syndrome considerably promoted normalization of IL−6 and TNF−α in the blood serum and depended on the dose. More considerable reduction of IL−6 can be achieved using minimum doses of lisinopril with carvedilol.
Key words: coronary artery disease, chronic heart failure, diabetes mellitus, metabolic syndrome, lisinopril, carvedilol.